focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.025
Bid: 1.00
Ask: 1.05
Change: 0.00 (0.00%)
Spread: 0.05 (5.00%)
Open: 1.025
High: 1.025
Low: 1.025
Prev. Close: 1.025
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

End of Formal Sale Process

22 Dec 2020 07:00

RNS Number : 4424J
Microsaic Systems plc
22 December 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7OF THE REGULATION (EU) NO 596/2014 ON MARKET ABUSE

 

22 December 2020

 

Microsaic Systems plc

("Microsaic" or the "Company")

End of Formal Sale Process

Appointment of KRE Corporate Recovery Limited

Microsaic Systems plc (AIM: MSYS), regrets to announce that its formal sale process has concluded without securing any definitive offer for the Company or any other solution which would provide sufficient funding for the Company to pursue its business plans. As a result, the Company has appointed KRE Corporate Recovery Limited ("KRE") to explore other remaining options to maximise value for creditors and potentially other stakeholders.

As announced on 29 July 2020, following a market sounding exercise carried out in the middle of 2020, the Board had concluded that the prevailing conditions were not supportive at that time of raising sufficient equity from public market investors to fund the business through to profitability. The Board, had, therefore, appointed BDO LLP as its financial adviser, with regards to a Strategic Review, including a formal sale process for the purposes of Rule 3 of the City Code on Takeovers and Mergers (the "Takeover Code").

Since then, a very extensive process has been undertaken with outbound and inbound approaches to and from a large number of parties. From discussions with multiple potentially interested parties during the formal sale process, it became clear that their key considerations included the effect of the Covid-19 pandemic on their own businesses, the future investment required to take the Microsaic business to positive cash generation, and the continuing uncertainty around forward trading assumptions due to the ongoing impact of the pandemic. Following the cessation of discussions with the last remaining interested party, the formal sale process has regrettably now concluded without securing any definitive offer for the shares of the Company or for any other solution which would provide sufficient funding for the Company to pursue its business plans.

The interim results announcement on 2 September 2020 included the following statement on going concern:

"In view of the inherent uncertainties implicit in a Strategic Review process, there is a material uncertainty related to going concern. If the Strategic Review does not result in an appropriate outcome, the Directors would have to consider other actions for protecting stakeholders' interests."

In the light of the outcome of the formal sale process, the Board has now considered what actions are appropriate to protect stakeholders' interests. In particular, the Board has taken advice on the best way of maximising value for creditors and potentially other stakeholders and has, therefore, appointed KRE to run a process to offer the business and assets of the Company for sale. This process is expected to run until around the end of January 2021 and, based on facts presently known, the Board believes that the Company has sufficient cash to make essential, ongoing payments falling due during this period. Contact details for KRE are included below and any potentially interested parties are encouraged to contact KRE at the earliest possible opportunity.

At this time, no party has been identified which is prepared to make an offer for the Company, or its business and assets and there can be no certainty that any transaction will be concluded, nor as to the terms on which any form of transaction would be made. A sale of the business and assets might involve an administration process.

It is possible (but not certain) that a sale of the Company's business and assets may be effected following the appointment of an administrator. In the event that KRE identifies that the sale of the Company's business and assets is unlikely to generate incremental value for creditors or other stakeholders, the Board would have to initiate steps to appoint a liquidator to wind-up the Company's affairs. Any appointment of an administrator or liquidator would be likely to trigger immediate suspension of the Company's shares from admission to trading on AIM. In addition, if the Company were to go into administration or liquidation, additional costs would be incurred and liabilities may accelerate or crystallise which would diminish the potential realisations for stakeholders.

Following this announcement, the Company is no longer considered to be in an "offer period" as defined in the Takeover Code.

 

For further information, please contact:

Microsaic Systems plc

+44 (0) 1483 751 577

Glenn Tracey, CEO

Bevan Metcalf, FD

 

N+1 Singer (Nominated Adviser & Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

KRE Corporate Recovery Ltd

Gareth Roberts, Director (gareth.roberts@krecr.co.uk)

David Taylor, Director (david.taylor@krecr.co.uk)

+44 (0) 7979 706 392

+44 (0) 7855 231 103

 

 

Important notices

This announcement contains inside information for the purposes of Article 7 of the Regulation (EU) No 596/2014 on Market Abuse. Upon the publication of this announcement, this information is considered to be in the public domain.

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFEAESFESSELE
Date   Source Headline
14th Sep 20163:38 pmRNSGrant of Options
13th Sep 20164:46 pmRNSHolding(s) in Company
13th Sep 201610:45 amRNSHolding(s) in Company
13th Sep 20168:40 amRNSHolding(s) in Company
13th Sep 20168:30 amRNSDirector/PDMR Shareholding
12th Sep 201611:53 amRNSResult of GM, Completion of Placing, TVRs
26th Aug 20164:49 pmRNSResult of Placing
26th Aug 20161:15 pmRNSProposed Placing of New Shares
26th Aug 20161:15 pmRNSHalf-year Report
20th Jun 20163:27 pmRNSAGM Statement
13th Jun 20167:00 amRNSChange of Nominated Adviser and Broker
19th May 20167:00 amRNSDistribution of Annual Report and Accounts
13th May 201612:57 pmRNSAGM Change of Date
16th Mar 20167:00 amRNSAnnual Financial Report
8th Mar 20167:00 amRNSDirectorate Change
24th Feb 20167:00 amRNSTrading Statement
14th Jan 20167:00 amRNSAward of Options
21st Dec 20157:00 amRNSDirectorate Change
2nd Dec 20157:04 amRNSTrading Update & Directorate Change
30th Nov 201511:47 amRNSHolding(s) in Company
23rd Oct 201511:41 amRNSHolding(s) in Company
22nd Oct 20151:12 pmRNSHolding(s) in Company
19th Oct 20151:37 pmRNSResults of EGM and Placing
15th Oct 20157:00 amRNSPlacing - Exercise of Additional Demand Option
13th Oct 20153:30 pmRNSDirector/PDMR Shareholding
30th Sep 20157:44 amRNSPlacing of New Shares
30th Sep 20157:00 amRNSInterim Results
20th May 20157:00 amRNSResult of AGM
8th Apr 20158:34 amRNSNotification of Major Interest in Shares
30th Mar 20157:00 amRNSDistribution of Annual Report and Accounts
23rd Mar 20157:00 amRNSAnnual Financial Report
19th Mar 20157:00 amRNSAppoinment of Chief Operating Officer
16th Mar 20157:00 amRNSOEM Supply Agreement with GE Healthcare
6th Jan 20158:40 amRNSExercise of Share Options
28th Oct 20149:16 amRNSHolding(s) in Company
14th Oct 20142:10 pmRNSHolding(s) in Company
10th Oct 20144:19 pmRNSHolding(s) in Company
10th Oct 20141:15 pmRNSExercise of Share Options
8th Oct 20147:00 amRNSDirectors' Dealings
7th Oct 20147:00 amRNSConditional Placing to Raise £4.4 million
30th Sep 20147:00 amRNSInterim Results
29th Sep 201412:23 pmRNSCommercial Agreement with Gilson Inc.
25th Sep 20147:00 amRNSMicrosaic Systems Signs Commercial Agreement
9th Sep 20147:00 amRNSPlexus chosen as commercial manufacturing partner
15th Jul 201410:06 amRNSDirectorate Change
23rd Jun 20143:08 pmRNSHolding(s) in Company
19th Jun 201412:02 pmRNSHolding(s) in Company
13th Jun 20149:00 amRNSDISTRIBUTION OF ANNUAL REPORT & ACCOUNTS
10th Jun 20149:10 amRNSExercise of share options
3rd Jun 20147:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.